The State of Metabolic Health in America, 2026 Baseline Edition · James M. Knox · DOI: 10.5281/zenodo.22772957 · Last reviewed: October 2026

Employer Innovation

Series EN · The State of Metabolic Health in America, 2026 Baseline Edition

Overview

Employer benefit design decisions for GLP-1 medications, including coverage continuation intent, utilization control tightening, and variation across employer surveys with different populations and question designs.

This series contains 10 metrics in the 2026 Baseline Edition. Each metric cites a primary source. Where sources disagree, both figures and the reason for the discrepancy are documented rather than reconciled.

Metrics in This Series

Series EN metrics — The State of Metabolic Health in America, 2026 Baseline Edition
Metric IDMetricValueData YearPrimary Source
EN-01Large employers likely to continue GLP-1 coverage in 2027 (BGH survey)72%2026Business Group on Health 2026 survey (105 large-employer members)
EN-02Large employers unlikely to continue GLP-1 coverage in 2027 (BGH survey)10%2026Business Group on Health 2026 survey
EN-03Large employers intending to maintain GLP-1 coverage (WTW survey)70%June 2026WTW June 2026 survey
EN-04Large employers likely or very likely to discontinue GLP-1 coverage (WTW)12%June 2026WTW June 2026 survey
EN-05Large employers somewhat likely to discontinue GLP-1 coverage (WTW)18%June 2026WTW June 2026 survey
EN-06Employers that dropped GLP-1 coverage in 2026 (Mercer)6%2026Mercer National Survey of Employer-Sponsored Health Plans 2025
EN-07Employers that tightened GLP-1 utilization controls in 2026 (Mercer)27–30%2026Mercer National Survey of Employer-Sponsored Health Plans 2025
EN-08IFEBP survey: employers covering GLP-1s for both diabetes and weight loss36%2025International Foundation of Employee Benefit Plans survey
EN-09BGH survey: large employers with weight-management GLP-1 coverage67%2026Business Group on Health 2026 survey
EN-10WTW survey: employers with weight-management GLP-1 coverage66%2026WTW 2026 survey

Methodological Notes

Metrics in this series draw on federal surveys, administrative data, and peer-reviewed literature. Where two sources report different figures for the same condition, both are documented with the reason for the discrepancy — typically differences in survey population, measurement method, or case definition.

See Methodology for the full source selection criteria, metric ID system, and conflict resolution approach.

Data Gaps in This Series

Specific data gaps for this series are documented on the Data Gaps page. The report names what is not measured rather than estimating missing values.

How to cite this page

Knox, J. M. (2026). Employer Innovation (Series EN). In The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

© 2026 James M. Knox. Figures may be reproduced with attribution: Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957 ISSN 3144-8178 (Online)